BIOCONCEPT AG – Trademark Portfolio

Entity Type: 03

BIOCONCEPT AG holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 3 filings in this category. The portfolio also extends into Class 1 (Chemicals) across 2 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include AMIMED, MAM-PF, and BIOCONCEPT. The owner is based in ALLSCHWIL.

PARADIESRAIN 14

ALLSCHWIL 4123 , CH

4 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

MAM-PF
MAM-PF
Registered 2010
AMIMED
AMIMED
Registered 2003
AMIMED
AMIMED
Registered 2002

Trademark Classifications

BIOCONCEPT AG's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (3 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

1
Chemicals (2 filings)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

Frequently Asked Questions

How many trademarks does BIOCONCEPT AG have?

BIOCONCEPT AG has 4 U.S. trademarks filed with the USPTO. Of these, 4 registered.

What trademark classes does BIOCONCEPT AG file in?

BIOCONCEPT AG files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 1 (Chemicals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are BIOCONCEPT AG's most well-known trademarks?

BIOCONCEPT AG's registered trademark portfolio includes well-known marks such as AMIMED, MAM-PF, and BIOCONCEPT. These are among 4 currently registered trademarks in the portfolio.

What is BIOCONCEPT AG's trademark registration success rate?

BIOCONCEPT AG has a 100% trademark registration rate, with 4 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.